.png)
This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, JournalTOCs, JournalSeek, CrossRef, EZB Nutzeranfragen, RoMEO, AcademicKeys, CNKI, J-Gate
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Galenkamp H, Braam AW, Huisman M, Deeg DJH. Self-rated health: when and how to use it in epidemiological studies among older people? OA Epidemiology 2014 Sep 19;2(2):11.
High Impact
Schuurman MS, Groen HJM, Pruim J, Janssen-Heijnen MLG, Pukkala E, Siesling S. Temporal trends and spatial variation in stage distribution of non-small cell lung cancer in the Netherlands. OA Epidemiology 2014 Jul 18;2(1):10.
High Impact
Groenwold RHH, Uddin MJ, Roes KCB, de Boer A, Rivero-Ferrer E, Martin E, Gatto NM, Klungel OH. Instrumental variable analysis in randomized trials with non-compliance and observational pharmacoepidemiologic studies. OA Epidemiology 2014 May 09;2(1):9.
High Impact
van Ballegooijen AJ. A potential role for parathyroid hormone in cardiovascular disease. OA Epidemiology 2014 Apr 18;2(1):8.
High Impact
Pogreba-Brown K, Ernst K, Harris RB. Case-case methods for studying enteric diseases: A review and approach for standardization. OA Epidemiology 2014 Apr 18;2(1):7.
High Impact
Pundole X, Amirian ES, Scheurer ME. Role of varicella zoster virus in glioma risk: Current knowledge and future directions. OA Epidemiology 2014 Mar 22;2(1):6.
High Impact
Bosma H. Social epidemiology: Shuttling between upstream and downstream: A personal and narrative review. OA Epidemiology 2014 Mar 22;2(1):5.
High Impact
Manders P, Siezen AE, Gazzoli S, Smit C, Swinkels DW, Zielhuis GA. Radboud Biobank: a central facility for prospective clinical biobanking in the Radboud university medical center, Nijmegen. OA Epidemiology 2014 Feb 10;2(1):4.
High Impact
Ramaekers B, Grutters J, Joore M. Acknowledging patient heterogeneity in health technology assessment. OA Epidemiology 2014 Feb 10;2(1):3.
High Impact
Freeman MD, Cahn PJ, Franklin FA. Applied Forensic Epidemiology, Part 1: Medical Negligence OA Epidemiology 2014 Jan 18;2(1):2.
High Impact
Sobczak F, Burdorf A, Zeegers M. Law and epidemiology: Misinterpretation of epidemiologic information in claims for asbestos-related diseases. OA Epidemiology 2014 Jan 18;2(1):1.
High Impact
J?źwiak K, Moerbeek M. Optimal designs for trials with discrete-time survival endpoints. OA Epidemiology 2013 Dec 30;1(3):22.
High Impact
Tan FES. Confounding in (non-) randomized comparison studies. OA Epidemiology 2013 Dec 30;1(3):21.
High Impact
Schuurman MS, Groen HJM, Pruim J, Janssen-Heijnen MLG, Pukkala E, Siesling S. Temporal trends and spatial variation in stage distribution of non-small cell lung cancer in the Netherlands. OA Epidemiology 2014 Jul 18;2(1):10.
High Impact
Galenkamp H, Braam AW, Huisman M, Deeg DJH. Self-rated health: when and how to use it in epidemiological studies among older people? OA Epidemiology 2014 Sep 19;2(2):11.
High Impact
Pundole X, Amirian ES, Scheurer ME. Role of varicella zoster virus in glioma risk: Current knowledge and future directions. OA Epidemiology 2014 Mar 22;2(1):6.
High Impact
Nan C, Gielen M, Warner C, Krone RE, Mellers D, Martin W, Sunanda G, Bakour S, Barrett T, Zeegers M. Antenatal head circumference is associated with developmental skills in healthy twins: A study up to 24 months into infancy. OA Epidemiology 2013 Nov 01;1(2):17.
High Impact
Bongers BC, van Brussel M, Hulzebos HJ, Takken T. Paediatric exercise testing in clinics and classrooms: A comparative review of different assessments. OA Epidemiology 2013 Sep 01;1(2):14.
High Impact
Pearce N. Global epidemiology: the importance of international comparisons and collaborations. OA Epidemiology 2013 Oct 01;1(2):15.
High Impact
Pogreba-Brown K, Ernst K, Harris RB. Case-case methods for studying enteric diseases: A review and approach for standardization. OA Epidemiology 2014 Apr 18;2(1):7.
High Impact
Groenwold RHH, Uddin MJ, Roes KCB, de Boer A, Rivero-Ferrer E, Martin E, Gatto NM, Klungel OH. Instrumental variable analysis in randomized trials with non-compliance and observational pharmacoepidemiologic studies. OA Epidemiology 2014 May 09;2(1):9.
High Impact
Bosma H. Social epidemiology: Shuttling between upstream and downstream: A personal and narrative review. OA Epidemiology 2014 Mar 22;2(1):5.
High Impact
van der Meij BS, Bauer JD, Isenring EA, Brown T, Davidson WL, van Bokhorst MAE, Langius JAE, van Leeuwen PAM. The effects of supplementation of n-3 polyunsaturated fatty acids on clinical outcome parameters in patients with cancer: a systematic review. OA Epidemiology 2013 Apr 19;1(1):2.
High Impact
Grill E, M?ller M, Brandt T, Jahn K. Vertigo and dizziness: challenges for epidemiological research. OA Epidemiology 2013 Aug 01;1(2):12.
High Impact
Wesselius A, Zeegers MP. Direct-to-consumer genetic testing. OA Epidemiology 2013 May 30;1(1):4.
High Impact
Kessels AGH, ter Riet G, Puhan MA, Kleijnen J, Bachmann LM, Minder C. A simple regression model for network meta-analysis. OA Epidemiology 2013 Jul 22;1(1):7.
High Impact
Galenkamp H, Braam AW, Huisman M, Deeg DJH. Self-rated health: when and how to use it in epidemiological studies among older people? OA Epidemiology 2014 Sep 19;2(2):11.
High Impact
Schuurman MS, Groen HJM, Pruim J, Janssen-Heijnen MLG, Pukkala E, Siesling S. Temporal trends and spatial variation in stage distribution of non-small cell lung cancer in the Netherlands. OA Epidemiology 2014 Jul 18;2(1):10.
High Impact
Groenwold RHH, Uddin MJ, Roes KCB, de Boer A, Rivero-Ferrer E, Martin E, Gatto NM, Klungel OH. Instrumental variable analysis in randomized trials with non-compliance and observational pharmacoepidemiologic studies. OA Epidemiology 2014 May 09;2(1):9.
High Impact
van Ballegooijen AJ. A potential role for parathyroid hormone in cardiovascular disease. OA Epidemiology 2014 Apr 18;2(1):8.
High Impact
Pogreba-Brown K, Ernst K, Harris RB. Case-case methods for studying enteric diseases: A review and approach for standardization. OA Epidemiology 2014 Apr 18;2(1):7.
High Impact
Pundole X, Amirian ES, Scheurer ME. Role of varicella zoster virus in glioma risk: Current knowledge and future directions. OA Epidemiology 2014 Mar 22;2(1):6.
High Impact
Bosma H. Social epidemiology: Shuttling between upstream and downstream: A personal and narrative review. OA Epidemiology 2014 Mar 22;2(1):5.
High Impact
Manders P, Siezen AE, Gazzoli S, Smit C, Swinkels DW, Zielhuis GA. Radboud Biobank: a central facility for prospective clinical biobanking in the Radboud university medical center, Nijmegen. OA Epidemiology 2014 Feb 10;2(1):4.
High Impact
Ramaekers B, Grutters J, Joore M. Acknowledging patient heterogeneity in health technology assessment. OA Epidemiology 2014 Feb 10;2(1):3.
High Impact
Freeman MD, Cahn PJ, Franklin FA. Applied Forensic Epidemiology, Part 1: Medical Negligence OA Epidemiology 2014 Jan 18;2(1):2.
High Impact
Sobczak F, Burdorf A, Zeegers M. Law and epidemiology: Misinterpretation of epidemiologic information in claims for asbestos-related diseases. OA Epidemiology 2014 Jan 18;2(1):1.
High Impact
J?źwiak K, Moerbeek M. Optimal designs for trials with discrete-time survival endpoints. OA Epidemiology 2013 Dec 30;1(3):22.
High Impact
Tan FES. Confounding in (non-) randomized comparison studies. OA Epidemiology 2013 Dec 30;1(3):21.
High Impact
